Artemis Therapeutics Inc. (OTCMKTS:ATMS) Sees Large Decrease in Short Interest
Artemis Therapeutics Inc. (OTCMKTS:ATMS) Sees Large Decrease in Short Interest
Artemis Therapeutics Inc. (OTCMKTS:ATMS – Get Rating) saw a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 700 shares, a decline of 61.1% from the October 15th total of 1,800 shares. Based on an average daily trading volume, of 2,400 shares, the days-to-cover ratio is presently 0.3 days.
Artemis Therapeutics Stock Performance
Artemis Therapeutics stock opened at $1.40 on Friday. Artemis Therapeutics has a 1 year low of $0.55 and a 1 year high of $5.00. The business has a 50-day moving average of $1.96 and a 200-day moving average of $2.49.
Get Artemis Therapeutics alerts:Artemis Therapeutics Company Profile
(Get Rating)
Artemis Therapeutics Inc, a beauty company, develops and distributes skincare products in Israel. The company offers face serum with manuka honey and bee venom, face serum with enhanced vitamin C, day cream, night nourishing cream with manuka honey and nee venom, eye cream with manuka honey and bee venom, and face cleanser gel.Featured Articles
- Get a free copy of the StockNews.com research report on Artemis Therapeutics (ATMS)
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
Artemis Therapeutics Inc. (OTCMKTS:ATMS – Get Rating) saw a large decline in short interest in the month of October. As of October 31st, there was short interest totalling 700 shares, a decline of 61.1% from the October 15th total of 1,800 shares. Based on an average daily trading volume, of 2,400 shares, the days-to-cover ratio is presently 0.3 days.
Artemis治療公司(場外交易代碼：ATMS-GET Rating)在10月份看到空頭股數的銷售額大幅下降。截至10月31日，空頭股數共有700股，較10月15日的1,800股下降了61.1%。以日均成交量2,400股計算，目前天數與回補比率為0.3天。
Artemis Therapeutics Stock Performance
Artemis治療公司股票表現
Artemis Therapeutics stock opened at $1.40 on Friday. Artemis Therapeutics has a 1 year low of $0.55 and a 1 year high of $5.00. The business has a 50-day moving average of $1.96 and a 200-day moving average of $2.49.
Artemis治療公司的股票週五開盤報1.40美元。Artemis Treeutics的一年低點為0.55美元，一年高位為5.00美元。該業務的50日移動均線切入位在1.96美元，200日移動均線切入位在2.49美元。
Artemis Therapeutics Company Profile
Artemis治療公司簡介
(Get Rating)
(獲取評級)
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on Artemis Therapeutics (ATMS)
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
- 免費獲取StockNews.com關於Artemis治療(ATMS)的研究報告
- 中盤Neurocrine生物科學是井噴後的第三季度報告嗎？
- 六面旗幟是一種你不想被困住的旅程
- Hanesbrand可能發出零售類股本週表現不佳的信號
- 願景氫，現在的願景能源，將希望寄託在股票拆分上
- 優惠券股票和你為什麼應該關心
Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
接受Artemis治療日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Artemis治療公司和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧